Objective: To assess the effects of berberine and metformin on glucose in patients with type 2 diabets mellitus (T2DM) with a systematic review and meta-analysis. Methods: The databases including PubMed, Excerpta Medica Database (EMBase), Cochrane Library, Chinese National Knowledge Infrastructure database (CNKI), WanFang, the Chinese Scientific and Technical Journals database (VIP), China Doctor Dissertation Full-text Database (CDFD) and China Master Dissertation Full-text Database (CMFD) from the inception to April 2021 in Chinese or English language were searched. Randomized controlled trials (RCTs) of berberine only or combined with metformin versus metformin were included. Data extraction and paper quality assessment were conducted according to the Cochrane Handbook. RevMan 5.4 was used for the meta-analysis. Results: A total of thirteen studies were included, covering 1173 participants. The clinical heterogeneity of the included trials was relatively high. The methodological quality of most trials was generally low with bias in terms of random sequence generation, allocation concealment, blinding method, outcome data and selective reporting. Interventions were divided into two subgroups for analysis. Meta-analysis suggested that there was no statistical significance in the hypoglycemic effect between berberine and metformin for T2DM. However, berberine combined with metformin could reduce fasting plasma glucose (FPG) [MD = −1.49, 95% CI (−2.22, −0.76), P < 0.0001], 2-hour postprandial blood glucose (2hPG) [MD = −1.89, 95% CI (−2.94, −0.84), P = 0.0004], glycosylated hemoglobin A1c (HbA1c) [MD = −0.65, 95% CI (−0.91, −0.40), P < 0.00001] and homeostasis model assessment of insulin resistance (HOMA-IR) [MD = −0.53, 95% CI (−1.03, −0.03), P = 0.04] levels significantly compared with metformin group.
References
[1]
Arslanian, S. (2002) Type 2 Diabetes in Children: Clinical Aspects and Risk Factors. Hormone Research in Paediatrics, 57, 19-28. https://doi.org/10.1159/000053308
[2]
Guariguata, L., Witing, D.R., Hambleton, I., Beagley, J., Linnenkamp, U. and Shaw, J.E. (2014) Global Estimates of Diabetes Prevalence for 2013 and Projections for 2035. Diabetes Research and Clinical Practice, 103, 137-149.
https://doi.org/10.1016/j.diabres.2013.11.002
[3]
Chinese Diabetes Society (2021) Guideline for the Prevention and Treatment of Type 2 Diabetes Mellitus in China (2020 Edition) (Part 1). Chinese Journal of Practical Internal Medicine, 41, 668-695.
Duncan, L.I. and Clarke, B.F. (1965) Pharmacology and Mode of Action of the Hypoglycaemic Sulphonylureas and Diguanides. Annual Review of Pharmacology, 5, 151-162. https://doi.org/10.1146/annurev.pa.05.040165.001055
[6]
Blonde, L., Dipp, S. and Cadena, D. (2018) Combination Glucose-Lowering Therapy Plans in T2DM: Case-Based Considerations. Advances in Therapy, 35, 939-965.
https://doi.org/10.1007/s12325-018-0694-0
[7]
Morales, D.R. and Morris, A.D. (2015) Metformin in Cancer Treatment and Prevention. Annual Review of Medicine, 66, 17-29.
https://doi.org/10.1146/annurev-med-062613-093128
[8]
Lamanna, C., Monami, M., Marchionni, N. and Mannucci, E. (2011) Effect of Metformin on Cardiovascular Events and Mortality: A Meta-Analysis of Randomized Clinical Trials. Diabetes, Obesity and Metabolism, 13, 221-228.
https://doi.org/10.1111/j.1463-1326.2010.01349.x
[9]
Bhat, A., Sebastiani, G. and Bhat, M. (2015) Systematic Review: Preventive and Therapeutic Applications of Metformin in Liver Disease. World Journal of Hepatology, 7, 1652-1659. https://doi.org/10.4254/wjh.v7.i12.1652
[10]
Breining, P., Jensen, J.B., Sundelin, E.I., Gormsen, L.C., Jakobsen, S., Busk, M., et al. (2018) Metformin Targets Brown Adipose Tissue in Vivo and Reduces Oxygen Consumption in Vitro. Diabetes, Obesity and Metabolism, 20, 2264-2273.
https://doi.org/10.1111/dom.13362
[11]
Neven, E., Vervaet, B., Brand, K., Gottwald-Hostalek, U., Opdebeeck, B., De Maré, A., et al. (2018) Metformin Prevents the Development of Severe Chronic Kidney Disease and Its Associated Mineral and Bone Disorder. Kidney International, 94, 102-113. https://doi.org/10.1016/j.kint.2018.01.027
[12]
Leng S.H., Lu, F.E. and Xu, L.J. (2004) Therapeutic Effects of Berberine in Impaired Glucose Tolerance Rats and Its Influence on Insulin Secretion. Acta Pharmaceutica Sinica, 25, 496-502.
[13]
Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., et al. (2004) Berberine Is a Novel Cholesterollowering Drug Working through a Unique Mechanism Distinct from Statins. Nature Medicine, 10, 1344-1351. https://doi.org/10.1038/nm1135
[14]
Lee, Y.S., Kim, W.S., Kim, K.H., Yoon, M.J., Cho, H.J., Shen, Y., et al. (2006) Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase with Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States. Diabetes, 55, 2256-2264. https://doi.org/10.2337/db06-0006
[15]
Derosa, G., D’Angelo, A., Bonaventura, A., Bianchi, L., Romano, D. and Maffioli, P. (2013) Effects of Berberine on Lipid Profile in Subjects with Low Cardiovascular Risk. Expert Opinion on Biological Therapy, 13, 475-482.
https://doi.org/10.1517/14712598.2013.776037
[16]
Affuso, F., Mercurio, V., Fazio, V. and Fazio, S. (2010) Cardiovascular and Metabolic Effects of Berberine. World Journal of Cardiology, 2, 71-77.
https://doi.org/10.4330/wjc.v2.i4.71
[17]
Lan, T., Shen, X., Liu, P., Liu, W., Xu, S., Xie, X., et al. (2010) Berberine Ameliorates Renal Injury in Diabetic C57BL/6 Mice: Involvement of Suppression of SphKS1P Signaling Pathway. Archives of Biochemistry and Biophysics, 502, 112-120.
https://doi.org/10.1016/j.abb.2010.07.012
[18]
Zhao, W., Xue, R., Zhou, Z.X., Kong, W.J. and Jiang, J.D. (2008) Reduction of Blood Lipid by Berberine in Hyperlipidemic Patients with Chronic Hepatitis or Liver Cirrhosis. Biomedicine & Pharmacotherapy, 62, 730-731.
https://doi.org/10.1016/j.biopha.2008.01.007
[19]
Ren, T.T., Suo, L.X., Chen, X.O., Yang, W., Tang, M.M. and Li, X.Q. (2018) Curative Effect Analysis of Berberine and Probiotics in Improving Intestinal of Metformin. Chinese Journal of Modern Drug Application, 12, 1-4.
https://doi.org/10.1080/17535654.2018.1469321
[20]
Liu, J.P., Zhang, M., Wang, W.Y. and Grimsgaard, S. (2004) Chinese Herbal Medicine for Type 2 Diabetes Mellitus. Cochrane Database of Systematic Reviews, No. 3. Article No. CD003642. https://doi.org/10.1002/14651858.CD003642.pub2
[21]
World Health Organization (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Part 1, Diagnosis and Classification of Diabetes Mellitus. World Health Organization, Geneva.
[22]
Chinese Diabetes Society (2014) Guidelines for the Prevention and Treatment of Type 2 Diabetes in Chian (2013). Chinese Journal of Endocrinology and Metabolism, 30, 893-942.
[23]
Higgins, J.P. and Green, S. Cochrane Handbook for Systematic Review of Interventions. Versin 5.1.0. http://www.cochrane-handbook.org
[24]
Yin, J., Xing, H. and Ye, J. (2008) Efficacy of Berberine in Patients with Type 2 Diabetes. Metabolism, 57, 712-717. https://doi.org/10.1016/j.metabol.2008.01.013
[25]
Xue, S.X., Xu, J.Q. and Zhan, L.L. (2012) Efficacy of Sulfonylureas Combined with Berberine and Metformin in Treatment of Diabetes Mellitus. Shaanxi Journal of Traditional Chinese Medicine, 33, 1335-1336.
[26]
Zhang, Y.D. and Yuan, X. (2012) Clinical Observation of Berberine in the Treatment of Type 2 Diabetes. Journal of Heze Medical College, 24, 27-28.
[27]
Zhang, H., Wei, J., Xue, R., Wu, J.-D., Zhao, W., Wang, Z.-Z., et al. (2010) Berberine Lowers Blood Glucose in Type 2 Diabetes Mellitus Patients through Increasing Insulin Receptor Expression. Metabolism, 59, 285-292.
https://doi.org/10.1016/j.metabol.2009.07.029
[28]
Cao Y. (2007) Clinical Study of Multifactorial Intervention to Improve Insulin Resistance in Type 2 Diabetes Mellitus. Shandong Traditional Chinese Medicine University, Shandong.
[29]
Li, M.L. (2008) Clinical Observation of Berberine Combined with Metformin in the Treatment of Type 2 Diabetes Mellitus. Hubei Journal of Traditional Chinese Medicine, 30, 34-35.
[30]
Liu, Z.M. (2013) Effect of Metformin Combined with Berberine in the Treatment of Type 2 Diabetes Mellitus. Zhejiang Journal of Integrated Traditional Chinese and Western Medicine, 23, 380-382.
[31]
Zhou, Q. and Huang, S.P. (2012) Clinical Study of Berberine Combined with Metformin in the Treatment of Obesity Type 2 Diabetes Mellitus. Journal of Practical Diabetology, 8, 33-35.
[32]
Zhan, H.J., Chen, H.Y., Lin, C.X., et al. (2015) Effects of Berberine on T2DM and High Lipid Serum NO Level in Patients with Hyperlipidemin and the Activity of SOD. Journal of North Pharmacy, 12, 119-121.
[33]
Lu, L.M., Zhang, L.P., Yin, Y.H., et al. (2013) Study on Thrapeutic Effect of Berberine Hydrochloride Combined with Metformin Treating Type 2 Diabetes Patients with Hyperlipidemia. World Chinese Medicine, 8, 1166-1168.
[34]
Jiang, W.L. and Wang, H.R. (2019) Effects of Berberine Hydrochloride Tablets Combined with Metformin on Blood Glucose Control and Quality of in Patients with Type 2 Diabetes Mellitus. Chronic Pathematology Journal, 20, 1228-1232.
[35]
Yang, X., Liu, Z.M. and Yang, H.J. (2020) Clinical Study on Berberine Hydrochloride Tablets Combined with Metformin in the Treatment of Primary Type 2 Diabetes. Shanghai Journal of Traditional Chinese Medicine, 54, 59-62.
[36]
Dong, K.L., Shang, J.J. and Tao, L. (2017) Effect of Berberine Combined with Metformin on Serum Imflammatory Factors and Islet Function in Type 2 Diabetes Mellitus. Journal of Clinical and Pathological Research, 37, 1418-1422.
[37]
Suhail, A.A., Iqbal, A.M., Tariq, Z.S., et al. (2017) Berberine Protects against Metformin-Associated Lactic Acidosis in Induced Diabetes Mellitus. Iranian Journal of Basic Medical Sciences, 20, 511-515.
[38]
Chen, W.N., Duan, S.J., Zeng, L.N., et al. (2015) Berberine versus Metformin in Treatment of Type 2 Diabetes: A Systematic Review of Randomized Control Trials. Journal of Liaoning University of TCM, 17, 151-154.
[39]
Lan, J.R., Zhao, Y.Y., Dong, F.X., Yan, Z., Zheng, W., Fan, J., et al. (2015) Meta-Analysis of the Effect and Safety of Berberine in the Treatment of Type 2 Diabetes Mellitus, Hyperlipemia and Hypertension. Journal of Ethnopharmacology, 161, 69-81. https://doi.org/10.1016/j.jep.2014.09.049
[40]
Bian, Z., Liu, B., Moher, D., Wu, T., Li, Y., Shang, H., et al. (2011) Consolidated Standards of Reporting Trials (CONSORT) for Traditional Chinese Medicine: Current Situation and Future Development. Frontiers of Medicine, 5, 171-177.
https://doi.org/10.1007/s11684-011-0132-z
